215P Impact of HER2 low on survival in patients treated with standard therapies in advanced breast cancer

Graff, S. L., Bansal, R., Adeyelu, T., Elliott, A., Bustos, M., Rodriguez, E., Accordino, M., Meisel, J., Gatti-Mays, M., Hsu, E., Lathrop, K. I., Kaklamani, V., Oberley, M., Sledge, G., & Sammons, S. (2023). 215P Impact of HER2 low on survival in patients treated with standard therapies in advanced breast cancer. ESMO Open, 8(1), 101404. https://doi.org/10.1016/j.esmoop.2023.101404
Authors:
Stephanie L. Graff
R. Bansal
T.T. Adeyelu
Andrew Elliott
M. Bustos
Estelamari Rodriguez
Melissa K. Accordino
Jane Meisel
Margaret E. Gatti‐Mays
Emily Hsu
Kate Lathrop
Virginia Kaklamani
Matthew J. Oberley
GW Sledge
Sarah Sammons
Affiliated Authors:
Melissa K. Accordino
Columbia Affiliation:
Subjects:
Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer (OpenAlex Topic)
HER2 Signaling in Breast Cancer Treatment (OpenAlex Topic)
Genomic Landscape of Cancer and Mutational Signatures (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1016/j.esmoop.2023.101404
DOI:
10.1016/j.esmoop.2023.101404
Journal:
ESMO Open
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: